Vol. 25 No. 4 (2020): Transformative Technologies Special Edition

Published: 2020-12-11

Commentary

What’s Coming Next in Transformative Innovation? Announcing “The Annual JCB Top 50 Organizations for Transformative Innovation in Biopharma, Med Tech and Digital Health”

Arthur A Boni
- Requires Subscription or Fee PDF (USD 25)
A Healthcare Pilgrim's Progress

Peter Pitts
- Requires Subscription or Fee PDF (USD 25)

Articles

Emerging, Transformative Technologies: Promises and Business Model Challenges

Arthur Boni, Dennis M. Gross
- Requires Subscription or Fee PDF (USD 25)
An introductory perspective on emerging, transformative technologies in biopharma: promises, challenges and impediments

Arthur A Boni
- Requires Subscription or Fee PDF (USD 25)
A framework for comparing R&D productivity at big pharma companies vs. biotech startups

Richard Murphey
- Requires Subscription or Fee PDF (USD 25)
Personalized Medicine by Design

Saul Kaplan
- Requires Subscription or Fee PDF (USD 25)
Augmenting Healthcare with Human-Centered Technologies

Christopher Moehle, Jessica Gibson
- Requires Subscription or Fee PDF (USD 25)
Solving Hard Problems with AI: Dramatically Accelerating Drug Discovery Through A Unique Public-Private Partnership

John Baldoni, Edmon Begoli, Dimitri Kusnezov, John MacWilliams
- Requires Subscription or Fee PDF (USD 25)
Lessons from Sovaldi: Fueling Innovation While Ensuring Access

Marc Watrous, PhD, Daniel S. Levine
- Requires Subscription or Fee PDF (USD 25)

From the Boardroom

The “Art of Collaborations”: Understanding the Anatomy of Transformative Transactions in Biopharma

Arthur A Boni
- Requires Subscription or Fee PDF (USD 25)
Commercializing the new frontier in DNA writing: Enzymatic synthesis

Michael J. Kamdar , J. William Efcavitch
- Requires Subscription or Fee PDF (USD 25)
Challenges for Transformative Innovation in Emerging Digital Health Organizations: advocating service design to address the multifaceted healthcare ecosystem

Arthur A Boni
- Requires Subscription or Fee PDF (USD 25)
Legal and Compliance Considerations When Bringing Cellular Therapies to Market

Amy Dow, Jennifer E. Michael , Lauren Sullivan
- Requires Subscription or Fee PDF (USD 25)